Aspen’s personalised Parkinson’s cell therapy to advance to Phase III

Aspen Neuroscience’s autologous, personalised stem cell therapy is set for a pivotal trial after it showed improved "ON" and ...
Drug Target Review

PRI-101 could become first disease-modifying Parkinson’s drug

Explore the promising early results of PRI-101, a new treatment for Parkinson's disease aimed at targeting neurodegeneration.

FDA-approved compound promotes neuroprotective effects in Parkinson's disease

Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), ...
South Carolina Public Radio

Research about Parkinson’s disease and stem cell therapy

This week, Bobbi Conner talks with MUSC's Dr. Vanessa Hinson about research underway to explore the use of stem cell therapy ...
Business Wire

TreeFrog Publishes Results of First Successful Bioproduction of a Parkinson’s Disease Cell Therapy in Scalable Bioreactor in Neurotherapeutics Journal

Publication demonstrates the cell therapy product for Parkinson’s Disease overcomes most complex challenges in bioproduction, while demonstrating full behavioral recovery in pre-clinical model ...
Seeking Alpha

Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease

BERLIN--(BUSINESS WIRE)-- Bayer announced today progress for two potential therapies against Parkinson’s disease (PD). A first participant received randomized treatment in the pivotal Phase III ...
Health.com

How Is Parkinson's Disease Treated?

Medications like levodopa and carbidopa may help you manage Parkinson's disease. You can try physical therapy to improve your balance, gait, and motor function. Deep brain stimulation is a surgical ...